FrancophonIA/ELRC3.0 huggingface dataset:
English: By lowering the blood pressure, the risks associated with high blood pressure, such as having a stroke, are reduced.
Slovenian: znižanjem krvnega tlaka se zmanjša možnost tveganj, povezanih z visokim krvnim tlakom, kot je na primer kap.
English: The most common side effects with Dafiro (seen in between 1 and 10 patients in 100) are headache, nasopharyngitis (inflammation of the nose and throat), influenza (flu), hypokalaemia (low blood potassium levels), various types of oedema (swelling), fatigue (tiredness), flushing (reddening), asthenia (weakness) and hot flushes.
Slovenian: Najpogostejši neželeni učinki zdravila Dafiro (opaženi pri 1 do 10 bolnikih od 100) so glavobol, nazofaringitis (vnetje nosne votline in grla), influenca (gripa), hipokaliemija (nizke ravni kalija v krvi), različne vrste edemov (oteklin), utrujenost, pordelost, astenija (oslabelost) in navali vročine.
English: Five main studies involving nearly 5,200 patients, mostly with mild to moderate hypertension, were carried out.
Slovenian: Opravili so pet glavnih študij, v katere je bilo vključenih skoraj 5 200 bolnikov z blago do zmerno hipertenzijo.
English: The patient may need to take separate tablets or capsules before switching to the combination tablet.
Slovenian: Bolnik bo morda moral pred prehodom na tablete s kombinacijo obeh učinkovin nekaj časa jemati učinkovini v ločenih tabletah ali kapsulah.
English: Angiotensin II is a powerful vasoconstrictor (a substance that narrows blood vessels).
Slovenian: Angiotenzin II je močan vazokonstriktor (snov, ki zožuje krvne žile).
English: Dafiro is taken by mouth as one tablet once a day with some water.
Slovenian: Zdravilo Dafiro se jemlje peroralno, in sicer se zaužije ena tableta na dan z malo vode.
English: What is the risk associated with Dafiro?
Slovenian: Kakšna tveganja so povezana z zdravilom Dafiro?
English: In the studies comparing the combination in patients who were already taking either amlodipine or valsartan, the blood pressure in patients taking valsartan alone had fallen by 6.6 mmHg after eight weeks, compared with 9.6 and 11.4 mmHg in the patients adding 5 or 10 mg amlodipine, respectively.
Slovenian: V študijah, v katerih so kombinacijo primerjali pri bolnikih, ki so že jemali amlodipin ali valsartan, je krvni tlak bolnikov, ki so prejemali samo valsartan, po osmih tednih padel za 6,6 mmHg v primerjavi z 9,6 in 11,4 mmHg pri bolnikih, ki so prejemali še dodatnih 5 mg oziroma 10 mg amlodipina.
English: When calcium ions enter the cells in the muscles of blood vessel walls, this causes contraction.
Slovenian: Kadar kalcijevi ioni vstopajo v celice mišic v žilnih stenah, se te začnejo krčiti.
English: The combination of amlodipine and valsartan was more effective at reducing blood pressure than placebo or either valsartan or amlodipine taken alone.
Slovenian: Kombinacija amlodipina in valsartana je bila pri nižanju krvnega tlaka učinkovitejša od placeba oziroma zdravljenja samo z valsartanom ali samo z amlodipinom.
English: For the full list of all side effects reported with Dafiro, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Dafiro, glejte navodilo za uporabo.
English: The dose of Dafiro to be used depends on the doses of amlodipine or valsartan that the patient was taking before.
Slovenian: Odmerek zdravila Dafiro, ki ga je treba vzeti, je odvisen od odmerkov amlodipina ali valsartana, ki ju je bolnik jemal prej.
English: Dafiro must not be used in patients who have severe liver or bile problems, patients with certain heart problems and patients with severe hypotension (low blood pressure).
Slovenian: Zdravila Dafiro prav tako ne smejo jemati bolniki, ki imajo hude težave z jetri ali izločanjem žolča, bolniki z nekaterimi obolenji srca ter bolniki s hudo hipotenzijo (nizkim krvnim tlakom).
English: By blocking the receptors to which angiotensin II normally attaches, valsartan stops the hormone having an effect, allowing the blood vessels to widen.
Slovenian: Ker valsartan ustavi njegovo delovanje z zaviranjem receptorjev, na katere se angiotenzin II običajno veže, hormonu prepreči učinkovanje, zaradi česar se krvne žile lahko razširijo.
English: Two studies (involving almost 3,200 patients) compared amlodipine, valsartan or a combination of both substances with placebo (a dummy treatment).
Slovenian: V dveh študijah (s skoraj 3 200 bolniki) so amlodipin, valsartana ali kombinacijo obeh učinkovin primerjali s placebom (zdravilom brez zdravilne učinkovine).
English: Dafiro is used in patients who have essential hypertension (high blood pressure) that is not adequately controlled on either amlodipine or valsartan taken alone.
Slovenian: Zdravilo Dafiro se uporablja pri bolnikih, ki imajo esencialno hipertenzijo (visok krvni tlak), ki je ni mogoče ustrezno uravnati samo z amlodipinom ali valsartanom.
English: Why has Dafiro been approved?
Slovenian: Zakaj je bilo zdravilo Dafiro odobreno?
English: Dafiro must not be used in patients who are hypersensitive (allergic) to amlodipine or other medicines in the ‘dihydropyridine derivatives' class, to valsartan, or to any of the other ingredients.
Slovenian: Zdravila Dafiro ne smejo uporabljati osebe, ki so preobčutljive za (alergične na) amlodipin ali druga zdravila iz razreda derivatov dihidropiridina, valsartan ali katero koli drugo sestavino zdravila.
English: Patients taking amlodipine alone had a fall of 10.0 mmHg, compared with 11.8 mmHg in the patients adding 160 mg valsartan.
Slovenian: Tlak bolnikov, ki so jemali le amlodipin, je padel za 10,0 mmHg v primerjavi z 11,8 mmHg pri bolnikih, ki so prejemali še dodatnih 160 mg valsartana.
English: Dafiro must also not be used in combination with aliskiren-containing medicines (also used to treat essential hypertension) in patients with type 2 diabetes or in patients with moderate or severe kidney impairment.
Slovenian: Zdravilo Dafiro se prav tako ne sme uporabljati v kombinaciji z zdravili, ki vsebujejo aliskiren (ki se uporablja za zdravljenje esencialne hipertenzije), pri bolnikih s sladkorno boleznijo tipa 2 ali zmerno do hudo ledvično okvaro.
English: Two studies (involving 1,891 patients) compared the combination in patients whose hypertension was not adequately controlled with either 10 mg amlodipine or 160 mg valsartan.
Slovenian: V dveh študijah (s 1 891 bolniki) so kombinacijo primerjali pri bolnikih, pri katerih 10-miligramski odmerek amlodipina ali 160-miligramski odmerek valsartana nista učinkovito uravnala hipertenzije.
English: Dafiro is a medicine that contains two active substances, amlodipine and valsartan.
Slovenian: Dafiro je zdravilo, ki vsebuje dve zdravilni učinkovini, amlodipin in valsartan.
English: By reducing the flow of calcium into the cells, amlodipine prevents the cells from contracting and this helps the blood vessels to relax.
Slovenian: Amlodipin z zmanjšanjem pretoka kalcija v celice prepreči njihovo krčenje in pomaga pri sproščanju sten žil ter tako znižuje krvni tlak.
English: The fifth, smaller study compared the combination with lisinopril and hydrochlorothiazide (another combination used to treat hypertension) in 130 patients with severe hypertension.
Slovenian: V peti, manjši študiji s 130 bolniki s hudo hipertenzijo so kombinacijo primerjali s lizinoprilom in hidroklorotiazidom (drugo kombinacijo zdravil za zdravljenje zvišanega krvnega tlaka).
English: What is Dafiro used for?
Slovenian: Za kaj se zdravilo Dafiro uporablja?
English: They work in similar ways to reduce blood pressure by allowing the blood vessels to relax.
Slovenian: Obe podobno način sproščata napetost žil, zaradi česar se zniža krvni tlak.
English: What is Dafiro?
Slovenian: Kaj je zdravilo Dafiro?
English: How does Dafiro work?
Slovenian: Kako zdravilo Dafiro deluje?
English: How has Dafiro been studied?
Slovenian: Kako je bilo zdravilo Dafiro raziskano?
English: Dafiro contains two active substances, amlodipine and valsartan.
Slovenian: Zdravilo Dafiro vsebuje dve zdravilni učinkovini, amlodipin in valsartan.
English: How is Dafiro used?
Slovenian: Kako se zdravilo Dafiro uporablja?
English: Approximately 25 µg
Slovenian: približno 25 µg
English: and tetanus toxoid (T), adsorbed (PRP-T)
Slovenian: vezan na tetanusni toksoid (T), adsorbiran (PRP-T)
English: 50 (5 X 10) vials + 50 (5 X 10) pre-filled syringes without needles (multipack)
Slovenian: 50 (5 X 10) vial + 50 (5 X 10) napolnjenih injekcijskih brizg brez igel (pakiranje, ki vsebuje več posameznih pakiranj)
English: MA (EU) number (Invented)n ame
Slovenian: Številka (EU) dovoljenja za promet
English: 10 vials + 10 pre-filled syringes + 20 needles
Slovenian: 10 vial + 10 napolnjenih injekcijskih brizg + 20 igel
English: _ _1 After reconstitution, 1 dose (0.5 ml) contains: Diphtheria toxoid, adsorbed
Slovenian: _ _1 Po rekonstituciji en odmerek cepiva (0,5 ml) vsebuje: davični toksoid, adsorbiran tetanusni toksoid, adsorbiran toksoid bordetele pertusis, adsorbiran filamentozni hemaglutinin, adsorbiran pertaktin, adsorbiran površinski antigen virusa hepatitisa B, rekombinantni (S protein), adsorbiran polisaharid hemofilusa tipa b (PRP)
English: 1 vial + 1 prefilled syringe + 2 needles
Slovenian: 1 viala + 1 napolnjena injekcijska brizga + 2 igli
English: 10 vials + 10 prefilled syringes without needles
Slovenian: 10 vial + 10 napolnjenih injekcijskih brizg brez igel
English: 1 vial + 1 prefilled syringe without needle
Slovenian: 1 viala + 1 napolnjena injekcijska brizga brez igle
English: Patients with open wounds, skin problems, high fever, severe infections and severe heart and circulation problems should not have full baths with lavender oil.
Slovenian: Bolniki z odprtimi ranami, težavami s kožo, zelo povišano telesno temperaturo, resnimi okužbami in resnimi težavami s srcem in krvnim obtokom ne smejo uporabljati kopeli z eteričnim oljem prave sivke za celo telo.
English: The plant is cultivated or gathered to obtain the oil for medicinal use.
Slovenian: Rastlina se goji ali nabira za pridobivanje eteričnega olja za uporabo v medicinske namene.
English: The HMPC concluded that, on the basis of its long-standing use, lavender oil can be used for the relief of mild symptoms of mental stress and exhaustion, and to aid sleep.
Slovenian: Odbor HMPC je zaključil, da se na podlagi njegove dolgotrajne uporabe eterično olje prave sivke lahko uporablja za lajšanje blagih simptomov stresa in izčrpanosti ter za pomoč pri spanju.
English: Lavender oil medicines should only be used in adults and children over the age of 12 years.
Slovenian: Zdravila, ki vsebujejo eterično olje prave sivke, se lahko uporabljajo samo pri odraslih in otrocih, starejših od 12 let.
English: For detailed information on the data assessed by the HMPC, see the HMPC assessment report.
Slovenian: Za podrobnejše informacije o podatkih, ki jih je ocenil odbor HMPC, glejte njegovo poročilo o oceni zdravila.
English: At the time of the HMPC assessment, there were no major concerns over the safety of lavender oil.
Slovenian: V času postopka ocenjevanja odbora HMPC ni bilo večjih zadržkov glede varnosti eteričnega olja prave sivke.
English: Lavender oil is the common name for the essential oil of the plant Lavandula angustifolia Mill.
Slovenian: Eterično olje prave sivke je splošno ime za eterično olje rastline Lavandula angustifolia Mill.
English: This summary is not intended to provide practical advice on how to use medicines containing lavender oil.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o uporabi zdravil, ki vsebujejo eterično olje prave sivke.
English: Although lavender oil showed a possible effect on anxiety, stress and insomnia, the number of patients per study was too low to establish an effect.
Slovenian: Čeprav so pokazale, da bi eterično olje prave sivke lahko imelo učinek na tesnobo, stres in nespečnost, je bilo število bolnikov v teh študijah premajhno za potrditev učinkovitosti.
English: Further information on the risks associated with lavender oil medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih z zdravili, ki vsebujejo eterično olje prave sivke, vključno z ustreznimi previdnostnimi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of lavender oil.
Slovenian: To je povzetek znanstvenih zaključkov Odbora za zdravila rastlinskega izvora (HMPC) v zvezi z medicinsko uporabo eteričnega olja prave sivke.
English: Only few and mild side effects had been reported in studies with lavender oil, including very rare cases of allergic reactions.
Slovenian: V študijah uporabe eteričnega olja prave sivke je bilo zabeleženih zgolj nekaj blagih neželenih učinkov, vključno z zelo redkimi primeri alergijskih reakcij.
English: In its assessment, the HMPC also considered studies with lavender oil in patients with different conditions, including anxiety and sleeping disorders.
Slovenian: Pri oceni je odbor HMPC upošteval tudi študije uporabe eteričnega olja prave sivke pri bolnikih z različnimi težavami, kot so tesnoba in motnje spanja.
English: Any applications for the licensing of medicines containing lavender oil have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo eterično olje prave sivke, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: This means that, although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in this way for at least 30 years (including at least 15 years within the EU).
Slovenian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom učinkovitost teh zdravil rastlinskega izvora verjetna in da obstajajo dokazi, da so se na navedeni način varno uporabljala že vsaj 30 let (najmanj 15 let tudi v EU).
English: Information on the use and licensing of lavender oil medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in dovoljenjih za promet z zdravili, ki vsebujejo eterično olje prave sivke, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: The HMPC conclusions on the use of medicines containing lavender oil are based on their ‘traditional use'.
Slovenian: Zaključki odbora HMPC o uporabi zdravil, ki vsebujejo eterično olje prave sivke, temeljijo na njihovi „tradicionalni uporabi“.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing lavender oil.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo eterično olje prave sivke.
English: Further information on the HMPC assessment of lavender oil, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo eterično olje prave sivke, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Herbal medicines containing lavender oil are usually available in liquid forms to be taken by mouth or as a bath additive.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo eterično olje prave sivke, so navadno na voljo v tekočih oblikah, ki se jemljejo peroralno (zaužijejo skozi usta) ali se dodajajo h kopelim.
English: What evidence supports the use of lavender oil medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo eterično olje prave sivke?
English: How are lavender oil medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo eterično olje prave sivke, odobrena v EU?
English: Detailed instruction on how to take lavender oil medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobne informacije o uporabi zdravil, ki vsebujejo eterično olje prave sivke, in o tem, kdo jih lahko uporablja, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: What is lavender oil?
Slovenian: Kaj je eterično olje prave sivke?
English: Therefore, the HMPC conclusions on the use of lavender oil medicines are based on their long-standing use.
Slovenian: Zato zaključki odbora HMPC glede uporabe zdravil, ki vsebujejo eterično olje prave sivke, temeljijo na njihovi dolgotrajni uporabi.
English: What are the risks associated with lavender oil medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo eterično olje prave sivke?
English: For more information about treatment with lavender oil, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo eterično olje prave sivke, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: For practical information about using lavender oil medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: Other information about lavender oil medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo eterično olje prave sivke
English: Lavender oil is obtained by a current of steam through the flowering tops of the plant.
Slovenian: Eterično olje prave sivke se pridobiva s parno destilacijo cvetov rastline.
English: Further information on Vitrakvi can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/vitrakvi.
Slovenian: Nadaljnje informacije za zdravilo Vitrakvi so na voljo na spletni strani agencije: ema.europa.eu/medicines/human/EPAR/vitrakvi.
English: In addition, the tumours shrank quickly (within 2 months).
Slovenian: Poleg tega je do njihovega zmanjšanja prišlo hitro (v dveh mesecih).
English: The dose for children is based on their body surface area (weight and height).
Slovenian: Odmerek za otroke temelji na njihovi telesni površini (telesni masi in višini).
English: This means that there is more evidence to come about the medicine, which the company is required to provide.
Slovenian: To pomeni, da se pričakujejo dodatni dokazi o zdravilu, ki jih mora zagotoviti podjetje.
English: Vitrakvi (larotrectinib)
Slovenian: Vitrakvi (larotrektinib)
English: The European Medicines Agency therefore concluded that its benefits are greater than its risks and that it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zato zaključila, da so koristi zdravila Vitrakvi večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: This data will come from the three ongoing studies which aim to confirm the benefits and safety of Vitrakvi and its longer term effect in children.
Slovenian: Ti podatki bodo izhajali iz treh trenutno potekajočih študij, katerih namen je potrditi koristi in varnost zdravila Vitrakvi in njegov dolgoročnejši učinek pri otrocih.
English: What measures are being taken to ensure the safe and effective use of Vitrakvi?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Vitrakvi?
English: Vitrakvi (larotrectinib) EMA/457887/2019
Slovenian: Vitrakvi (larotrektinib) EMA/457887/2019
English: Vitrakvi is available as a liquid (20 mg per ml) and capsules (25 and 100 mg) and is taken by mouth.
Slovenian: Zdravilo Vitrakvi je na voljo v obliki tekočine (20 mg/ml) in kapsul (25 mg in 100 mg), jemlje pa se peroralno.
English: The most common side effects with Vitrakvi (which may affect more than 1 in 5 people) are tiredness, dizziness, constipation, nausea, vomiting, anaemia (low red blood cell counts) and high blood levels of alanine aminotransferase and aspartate aminotransferase (a sign of liver problems).
Slovenian: Najpogostejši neželeni učinki zdravila Vitrakvi (ki se lahko pojavijo pri več kot 1 bolniku od 5) so utrujenost, omotica, zaprtje, navzea, bruhanje, anemija (nizko število rdečih krvnih celic) in visoke ravni alanin-aminotransferaze in aspartat-aminotransferaze v krvi (znak težav z jetri).
English: As for all medicines, data on the use of Vitrakvi are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Vitrakvi stalno spremljajo.
English: Other information about Vitrakvi
Slovenian: Druge informacije o zdravilu Vitrakvi
English: In addition, the short time taken to shrink the tumours is important in relieving patients' symptoms.
Slovenian: Poleg tega je kratek čas, potreben za zmanjšanje tumorjev, pomemben pri lajšanju simptomov pri bolnikih.
English: Since Vitrakvi has been given conditional authorisation, the company that markets Vitrakvi will provide further data on its effects.
Slovenian: Ker je zdravilo Vitrakvi pridobilo pogojno dovoljenje, bo podjetje, ki ga trži, zagotovilo nadaljnje podatke o njegovih učinkih.
English: Adult patients should take 100 mg twice a day for as long as the cancer is stable and the side effects are acceptable.
Slovenian: Odrasli bolniki morajo jemati 100-miligramski odmerek zdravila dvakrat na dan, dokler ostaja rakavo obolenje stabilno, neželeni učinki pa so znosni.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Vitrakvi have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Vitrakvi upoštevati zdravstveni delavci in bolniki, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: An overview of Vitrakvi and why it is authorised in the EU
Slovenian: Pregled zdravila Vitrakvi in zakaj je odobreno v EU
English: Vitrakvi is used in patients whose tumours are advanced, have spread to other parts of the body or are not amenable to surgery, and who have no satisfactory alternative treatments.
Slovenian: Zdravilo Vitrakvi se uporablja pri bolnikih, katerih tumorji so napredovali, se razširili na druge dele telesa ali jih ni mogoče kirurško odstraniti, ki nimajo drugih ustreznih možnosti zdravljenja.
English: Side effects reported with Vitrakvi are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Vitrakvi, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: Although studies are still underway, the results released so far show that it is effective at reducing the size of patients' tumours.
Slovenian: Čeprav študije še vedno potekajo, dosedanji rezultati že kažejo, da je zdravilo učinkovito pri zmanjševanju velikosti tumorjev.
English: Vitrakvi has been given ‘conditional authorisation'.
Slovenian: Zdravilo Vitrakvi je pridobilo „pogojno dovoljenje za promet“.
English: What is Vitrakvi and what is it used for?
Slovenian: Kaj je zdravilo Vitrakvi in za kaj se uporablja?
English: For more information about using Vitrakvi, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Vitrakvi glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.